Ansell Limited (PD1A) - Net Assets
Based on the latest financial reports, Ansell Limited (PD1A) has net assets worth €1.98 Billion EUR as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.32 Billion) and total liabilities (€1.34 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.98 Billion |
| % of Total Assets | 59.68% |
| Annual Growth Rate | 5.8% |
| 5-Year Change | 26.72% |
| 10-Year Change | 29.53% |
| Growth Volatility | 27.89 |
Ansell Limited - Net Assets Trend (2004–2025)
This chart illustrates how Ansell Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ansell Limited (2004–2025)
The table below shows the annual net assets of Ansell Limited from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €1.98 Billion | +3.80% |
| 2024-06-30 | €1.91 Billion | +18.25% |
| 2023-06-30 | €1.62 Billion | +3.78% |
| 2022-06-30 | €1.56 Billion | -0.51% |
| 2021-06-30 | €1.56 Billion | -23.49% |
| 2020-06-30 | €2.04 Billion | +1.68% |
| 2019-06-30 | €2.01 Billion | -4.11% |
| 2018-06-30 | €2.10 Billion | +31.30% |
| 2017-06-30 | €1.60 Billion | +4.36% |
| 2016-06-30 | €1.53 Billion | +31.21% |
| 2015-06-30 | €1.17 Billion | +2.29% |
| 2014-06-30 | €1.14 Billion | +90.97% |
| 2006-06-30 | €597.22 Million | +32.01% |
| 2005-06-30 | €452.40 Million | -25.50% |
| 2004-06-30 | €607.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ansell Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 128744668000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.10 Billion | 55.88% |
| Other Components | €866.40 Million | 44.12% |
| Total Equity | €1.96 Billion | 100.00% |
Ansell Limited Competitors by Market Cap
The table below lists competitors of Ansell Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
$2.79 Billion |
|
Taseko Mines Ltd
NYSE MKT:TGB
|
$2.79 Billion |
|
TechnoPro Holdings Inc
F:30T
|
$2.79 Billion |
|
Meitu Inc
F:M5U
|
$2.79 Billion |
|
Shenzhen Suntak Circuit Technology Co Ltd
SHE:002815
|
$2.79 Billion |
|
Iljin Electric Co
KO:103590
|
$2.79 Billion |
|
Medical Properties Trust Inc
NYSE:MPW
|
$2.78 Billion |
|
Orion Oyj A
HE:ORNAV
|
$2.78 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ansell Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,894,900,000 to 1,963,600,000, a change of 68,700,000 (3.6%).
- Net income of 101,600,000 contributed positively to equity growth.
- Dividend payments of 63,700,000 reduced retained earnings.
- Share repurchases of 4,400,000 reduced equity.
- Other factors increased equity by 35,200,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €101.60 Million | +5.17% |
| Dividends Paid | €63.70 Million | -3.24% |
| Share Repurchases | €4.40 Million | -0.22% |
| Other Changes | €35.20 Million | +1.79% |
| Total Change | €- | 3.63% |
Book Value vs Market Value Analysis
This analysis compares Ansell Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.24x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.57x to 1.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €10.69 | €16.80 | x |
| 2018-06-30 | €14.59 | €16.80 | x |
| 2019-06-30 | €15.07 | €16.80 | x |
| 2020-06-30 | €15.78 | €16.80 | x |
| 2021-06-30 | €12.18 | €16.80 | x |
| 2022-06-30 | €12.26 | €16.80 | x |
| 2023-06-30 | €12.70 | €16.80 | x |
| 2024-06-30 | €13.04 | €16.80 | x |
| 2025-06-30 | €13.52 | €16.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ansell Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.17%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.07%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.69x
- Recent ROE (5.17%) is below the historical average (12.58%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 10.28% | 7.99% | 0.72x | 1.79x | €1.68 Million |
| 2005 | 21.91% | 11.72% | 0.93x | 2.02x | €53.90 Million |
| 2006 | 14.46% | 10.27% | 0.77x | 1.83x | €26.65 Million |
| 2014 | 3.72% | 2.63% | 0.67x | 2.10x | €-70.70 Million |
| 2015 | 16.28% | 11.40% | 0.69x | 2.06x | €72.32 Million |
| 2016 | 14.19% | 10.12% | 0.69x | 2.04x | €63.29 Million |
| 2017 | 12.20% | 10.75% | 0.56x | 2.02x | €34.59 Million |
| 2018 | 31.56% | 32.51% | 0.59x | 1.64x | €447.63 Million |
| 2019 | 7.99% | 7.45% | 0.63x | 1.70x | €-40.13 Million |
| 2020 | 11.40% | 9.83% | 0.66x | 1.76x | €28.49 Million |
| 2021 | 15.90% | 12.17% | 0.74x | 1.76x | €91.58 Million |
| 2022 | 10.29% | 8.13% | 0.78x | 1.62x | €4.41 Million |
| 2023 | 9.26% | 8.96% | 0.65x | 1.58x | €-11.79 Million |
| 2024 | 4.04% | 4.72% | 0.50x | 1.71x | €-112.99 Million |
| 2025 | 5.17% | 5.07% | 0.60x | 1.69x | €-94.76 Million |
Industry Comparison
This section compares Ansell Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $58,533,430,469
- Average return on equity (ROE) among peers: -87.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ansell Limited (PD1A) | €1.98 Billion | 10.28% | 0.68x | $2.79 Billion |
| Modern Dental Group Limited (1MD) | $2.10 Billion | 7.38% | 0.49x | $661.80 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $692.18 Million | 21.94% | 0.78x | $2.39 Billion |
| Alcon Inc. (2U3) | $20.62 Billion | 4.72% | 0.44x | $32.45 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.67 Billion | 11.61% | 1.89x | $16.46 Billion |
| SHIP HEALTHCARE HLDG.INC. (5EZ) | $150.28 Billion | 10.07% | 1.54x | $1.23 Billion |
| JINS HOLDINGS INC. (5F3) | $21.78 Billion | 8.09% | 1.06x | $714.86 Million |
| NIPRO CORP. (5FA) | $269.79 Billion | 4.12% | 3.11x | $1.42 Billion |
| MENICON CO.LTD (5FR) | $74.66 Billion | 9.88% | 1.04x | $681.95 Million |
| Shofu Inc. (69W) | $42.73 Billion | 10.10% | 0.17x | $356.04 Million |
| MEDIMI AB AK (79T) | $332.69K | -959.52% | 4.12x | $427.04K |
About Ansell Limited
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves,… Read more